Unknown PHASE4 INTERVENTIONAL 2-arm NCT02188017

Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) (ACPS)

ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Sponsor: Mallinckrodt

Conditions Pulmonary Sarcoidosis Sarcoidosis

Interventions Acthar gel

Updated 7 times since 2017 Last updated: Dec 4, 2015 Started: Jun 30, 2014 Primary completion: Dec 31, 2016 Completion: Sep 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pulmonary Sarcoidosis and Sarcoidosis and is currently ongoing. Mallinckrodt leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Feb 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mallinckrodt
University of Cincinnati

Data source: University of Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States